C. Decroisette

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

R. Corre, Laurent Greillier, H. Le Caer et al. · Journal of Clinical Oncology · 2016 · 407 citations

Medicine, Geriatric Medicine, Oncology +17

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

Life Sciences, Immunology, Oncology +16

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018

Florian Guisier, Catherine Dubos‐Arvis, F. Viñas et al. · Journal of Thoracic Oncology · 2020 · 296 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

C. Decroisette, I. Monnet, H. Bérard et al. · Journal of Thoracic Oncology · 2011 · 134 citations

Medicine, Oncology, Pharmacoeconomics +17

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas

Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro‐Sibilot et al. · Lung Cancer · 2013 · 121 citations · Full text

Medicine, Oncology, Pathology +12